Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Cash from Operations (2021 - 2026)

Prokidney's (PROK) quarterly Cash from Operations came in at -$40.4 million in Q2 2026, down 28.51% year-over-year from -$56.5 million in Q2 2025, and up 3.14% quarter-over-quarter from -$41.7 million in Q1 2026.

Analysis

Prokidney (PROK) Cash from Operations (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Cash from Operations for 6 consecutive years, with -$40.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Operations fell 28.51% year-over-year to -$40.4 million in Q2 2026; TTM through Jun 2026 was -$141.2 million, a 23.38% decrease from a year earlier, with the FY2025 full-year figure at -$120.1 million, up 4.93% from the prior year.
  • Cash from Operations was -$40.4 million for Q2 2026 at Prokidney, up from -$41.7 million in the prior quarter.
  • Over five years, Cash from Operations peaked at -$14.9 million in Q2 2023 and troughed at -$41.7 million in Q1 2026.
  • A 5-year average of -$27.5 million and a median of -$26.3 million in 2023 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations plunged 11202073.91% in 2022 and surged 35.22% in 2023, its largest moves.
  • Over 5 years, Cash from Operations stood at -$15.8 million in 2022, then tumbled by 61.06% to -$25.4 million in 2023, then advanced by 4.78% to -$24.2 million in 2024, then plunged by 34.51% to -$32.5 million in 2025, then decreased by 24.18% to -$40.4 million in 2026.
  • The last three Cash from Operations figures came in at -$40.4 million (Q2 2026), -$41.7 million (Q1 2026), and -$32.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 74.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -83.50 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -60.82 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -20.90 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -28.58 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -66.10 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn -17.81 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 197.07 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 16.19 Mn
10 Prokidney 346.07 Mn 346.07 Mn - -40.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.37 Mn
Mar 31, 2026 -41.68 Mn
Dec 31, 2025 -32.51 Mn
Sep 30, 2025 -26.60 Mn
Jun 30, 2025 -31.42 Mn
Mar 31, 2025 -29.59 Mn
Dec 31, 2024 -24.17 Mn
Sep 30, 2024 -29.24 Mn
Jun 30, 2024 -38.29 Mn
Mar 31, 2024 -34.65 Mn
Dec 31, 2023 -25.38 Mn
Sep 30, 2023 -23.78 Mn
Jun 30, 2023 -14.92 Mn
Mar 31, 2023 -25.99 Mn
Dec 31, 2022 -15.76 Mn
Sep 30, 2022 -22.84 Mn
Jun 30, 2022 -23.03 Mn
Mar 31, 2022 -15.46 Mn
Dec 31, 2021 -1.21 Mn
Sep 30, 2021 -1.14 Mn